期刊文献+

鼠源TRAIL真核表达质粒的构建及其抑瘤效应的初步观察 被引量:1

Construction of Eukaryotic Expressing Plasmid of Mouse TRAIL and Its Inhibitory Effect on Tumor Growth
下载PDF
导出
摘要 采用 RT- PCR自小鼠脾细胞 RNA中扩增出鼠 TRAIL 基因的全长 c DNA,利用 DNA重组技术将其插入到真核表达载体 pc DNA3.1中获得重组质粒 p X1。经酶切鉴定及序列分析 ,表明成功构建 TRAIL 的真核表达质粒。通过直接肌肉内注射进行基因转染 ,p X1具有诱导肝癌细胞凋亡、抑制肝癌生长的作用。表明 TRAIL The mouse TRAIL cDNA was amplified from the RNA of the mouse spleen cells by using RT PCR and cloned into the eukaryotic expressing vector pcDNA3 by DNA recombinant technique to obtain the recombinant plasmid pX1. The eukaryotid expressing plasmid pX1 was constructed successfully which was confirmed by enzyme cleavage identification and sequencing identification. The transfection of plasmid pX1 by injection into muscle of mouse could produce the inhibitory effect on liver carcinoma growth by inducing cells into apoptosis. It was demonstrated that TRAIL could be applied into the gene therapy for liver carcinoma as a direct killing mechanism.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2002年第6期618-620,共3页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目 (No. 39870 76 3) 教育部跨世纪人才培养计划基金资助项目(教技厅 - 1997 2号文)
关键词 TRAIL 凋亡诱导配体 肝癌 基因治疗 TNF related apoptosis inducing ligand liver carcinoma gene therapy
  • 相关文献

参考文献3

二级参考文献5

共引文献28

同被引文献10

  • 1Seol J W,Chaudhari A A,Lee Y J,et al.Regulation of DR-5 protein and mitochondrial transmembrane potential by gemcitabine,a possible mechanism of gemcitabine-enhanced TRAIL-induced apoptosis[J].Oncol Rep,2007,18(3):523-529.
  • 2Wack S,Rejiba S,Parmentier C,et al.Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer[J].Mol Ther,2008,16(2):252-260.
  • 3Xu Z W,Kleeff J,Friess H,et al.Synergistic cytotoxic effect of TRAIL and gemcitabine in pancreatic cancer cells[J].Anticancer Res,2003,23(1A):251-258.
  • 4Kelley S K,Harris L A,Xie D,et al.Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor related apoptosis-inducing ligand in humans:Characterization of in vivo efficacy,pharmacokinetics,and safety[J].J Pharmacol Exp Ther,2001,299(1):31-38.
  • 5Mahalingam D,Szegezdi E,Keane M,et al.TRAIL receptor signalling and modulation:Are we on the right TRAIL?[J].Cancer Treat Rev,2009,35(3):280-288.
  • 6Wang H,Cao F,De A,et al.Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging[J].Stem Cells,2009,27(7):1548-1558.
  • 7Hu Y L,Fu Y H,Tabata Y,et al.Mesenchymal stem cells:a promising targeted-delivery vehicle in cancer gene therapy[J].J Control Release,2010,147(2):154-162.
  • 8Kidd S,Caldwell L,Dietrich M,et al.Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo,an effect countered by anti-inflammatory treatment[J].Cytotherapy,2010,12(5):615-625.
  • 9Mishra P J,Mishra P J,Humeniuk R,et al.Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells[J].Cancer Res,2008,68(11):4331-4339.
  • 10冯刚,张丽娟,罗利琼.转染pCE-GFP的重组骨髓间充质干细胞对Walker-256细胞的体外抗肿瘤作用[J].华中科技大学学报(医学版),2011,40(2):204-208. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部